Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year
May 10
German (DAX) Healthcare Sector Analysis
UpdatedMay 10, 2024
DataAggregated Company Financials
Companies62
- 7D1.5%
- 3M-1.7%
- 1Y-15.5%
- YTD-3.0%
In the last week, the Healthcare industry is up 1.5%, with Merck KGaA up 2.4%. In contrast, the industry has lost 16% in the last 12 months. Looking forward, earnings are forecast to grow by 20% annually.
Sector Valuation and Performance
Has the German Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 10 May 2024 | €233.5b | €159.4b | €3.8b | 24.6x | 61.8x | 1.5x |
| Sun, 07 Apr 2024 | €237.2b | €159.1b | €3.4b | 25.2x | 70x | 1.5x |
| Tue, 05 Mar 2024 | €242.9b | €178.9b | €3.4b | 21.2x | 72.5x | 1.4x |
| Thu, 01 Feb 2024 | €240.4b | €188.4b | €3.3b | 22.4x | 73x | 1.3x |
| Sat, 30 Dec 2023 | €244.3b | €188.4b | €3.3b | 21.7x | 74.7x | 1.3x |
| Mon, 27 Nov 2023 | €243.3b | €188.4b | €3.3b | 23.3x | 74.1x | 1.3x |
| Wed, 25 Oct 2023 | €233.0b | €189.3b | €8.6b | 21.7x | 27x | 1.2x |
| Fri, 22 Sep 2023 | €253.3b | €189.5b | €8.8b | 22.4x | 28.9x | 1.3x |
| Sun, 20 Aug 2023 | €258.9b | €189.4b | €8.9b | 24.2x | 29.2x | 1.4x |
| Tue, 18 Jul 2023 | €259.2b | €191.1b | €10.5b | 23.9x | 24.6x | 1.4x |
| Thu, 15 Jun 2023 | €272.4b | €191.0b | €10.5b | 24.2x | 26x | 1.4x |
| Sat, 13 May 2023 | €274.5b | €191.6b | €12.2b | 23.1x | 22.5x | 1.4x |
| Mon, 10 Apr 2023 | €287.8b | €190.6b | €12.6b | 23x | 22.8x | 1.5x |
| Wed, 08 Mar 2023 | €279.0b | €190.3b | €12.9b | 18.3x | 21.5x | 1.5x |
| Fri, 03 Feb 2023 | €291.7b | €187.6b | €13.9b | 18.4x | 21x | 1.6x |
| Sun, 01 Jan 2023 | €264.9b | €187.5b | €13.9b | 19.9x | 19.1x | 1.4x |
| Tue, 29 Nov 2022 | €276.3b | €187.4b | €13.8b | 20.1x | 20x | 1.5x |
| Thu, 27 Oct 2022 | €259.2b | €182.5b | €13.4b | 20.2x | 19.3x | 1.4x |
| Sat, 24 Sep 2022 | €219.5b | €178.5b | €12.9b | 17.7x | 17x | 1.2x |
| Mon, 22 Aug 2022 | €284.2b | €182.3b | €13.4b | 18.3x | 21.2x | 1.6x |
| Wed, 20 Jul 2022 | €281.7b | €178.5b | €11.3b | 23.8x | 24.9x | 1.6x |
| Fri, 17 Jun 2022 | €273.7b | €185.9b | €11.4b | 23.4x | 24x | 1.5x |
| Sun, 15 May 2022 | €290.6b | €185.6b | €11.3b | 22.3x | 25.7x | 1.6x |
| Tue, 12 Apr 2022 | €317.8b | €179.8b | €10.0b | 24.8x | 31.6x | 1.8x |
| Thu, 10 Mar 2022 | €294.6b | €179.4b | €10.4b | 22.3x | 28.3x | 1.6x |
| Sat, 05 Feb 2022 | €316.5b | €175.4b | €9.3b | 26.5x | 34.2x | 1.8x |
| Mon, 03 Jan 2022 | €353.2b | €175.4b | €9.3b | 29.8x | 38.1x | 2x |
| Wed, 01 Dec 2021 | €343.6b | €158.6b | €9.3b | 29x | 37.1x | 2.2x |
| Fri, 29 Oct 2021 | €338.2b | €154.6b | €1.3b | 29.2x | 261.6x | 2.2x |
| Sun, 26 Sep 2021 | €341.3b | €171.4b | €1.2b | 28.9x | 277.4x | 2x |
| Tue, 24 Aug 2021 | €351.6b | €171.3b | €1.3b | 31.6x | 281x | 2.1x |
| Wed, 30 Jun 2021 | €309.2b | €171.3b | €1.3b | 29.4x | 247.1x | 1.8x |
Price to Earnings Ratio
-41.5x
Current Industry PE
- Investors are relatively neutral on the German Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 59.4x.
- The industry is trading close to its 3-year average PS ratio of 1.6x.
Past Earnings Growth
- Total earnings for the Healthcare industry have gone up over the last three years, and the industry is now profitable.
- Revenues have remained mostly flat. This means that the industry has become more efficient since profits are increasing while sales have been flat.
Industry Trends
Which industries have driven the changes within the German Healthcare sector?
| DE Market | 2.49% | |
| Healthcare | 1.54% | |
| Pharma | 3.23% | |
| Medical Equipment | 1.61% | |
| Healthtech | 0.37% | |
| Biotech | -0.75% | |
| Life Sciences | -0.75% | |
| Healthcare Services | -1.33% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 51.9x.
- Analysts are expecting annual earnings growth of 26.5%, which is higher than its past year's earnings growth of 20.2% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 35% over the next 5 years.
- This is better than its past earnings decline of 28% per year.
- In contrast, the Biotech industry is expected to see its earnings decline by 47% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MRK Merck KGaA | €155.70 | 2.4% +€1.6b | -5.3% | PE24x | |
| BAYN Bayer | €28.69 | 2.4% +€658.2m | -46.6% | PS0.6x | |
| SHL Siemens Healthineers | €52.48 | 1.1% +€647.2m | -2.4% | PE31.8x | |
| DMP Dermapharm Holding | €35.05 | 4.6% +€83.5m | -20.2% | PE30.3x | |
| NXU Nexus | €56.60 | 8.6% +€77.7m | 11.0% | PE40.7x |
